Immutep (IMMP) Other Non-Current Liabilities (2014 - 2025)
Immutep (IMMP) posted Other Non-Current Liabilities of $18640.8 for Q4 2025, up 245.6% on a QoQ basis from $5393.7 in Q2 2025, and down 99.71% year-over-year from $6.4 million in Q4 2024.
Immutep (IMMP) Other Non-Current Liabilities (2014 - 2025) Analysis & Trends
Immutep's Other Non-Current Liabilities history runs 11 years deep, the most recent figure standing at $18640.8 for Q4 2025.
- Quarterly Other Non-Current Liabilities fell 99.71% year-over-year to $18640.8 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $18640.8 (down 99.71% YoY) and the FY2025 annual result came in at $5393.7, down 99.93% from the prior year.
- Other Non-Current Liabilities was $18640.8 for Q4 2025 at Immutep, up from $5393.7 in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $8.3 million in Q4 2021 and bottomed at $5164.8 in Q2 2024.
- A 5-year average of $2.7 million and a median of $557551.4 in 2021 frame the typical range for Other Non-Current Liabilities.
- Annual changes were most pronounced in 2021 — Other Non-Current Liabilities jumped 1077.83% — and 2025, when it slumped 99.71%.
- Immutep's Other Non-Current Liabilities stood at $8.3 million in 2021, then declined by 25.79% to $6.1 million in 2022, then fell by 13.4% to $5.3 million in 2023, then increased by 21.55% to $6.4 million in 2024, then slumped by 99.71% to $18640.8 in 2025.
- Business Quant data shows IMMP's Other Non-Current Liabilities at $18640.8 in Q4 2025, $5393.7 in Q2 2025, and $6.4 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Immutep | 567.77 Mn | 567.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 18,640.84 |
| Jun 30, 2025 | 5,393.73 |
| Dec 31, 2024 | 6.45 Mn |
| Jun 30, 2024 | 5,164.77 |
| Dec 31, 2023 | 5.30 Mn |
| Jun 30, 2023 | 558,379.06 |
| Dec 31, 2022 | 6.12 Mn |
| Jun 30, 2022 | 94,472.93 |
| Dec 31, 2021 | 8.25 Mn |
| Jun 30, 2021 | 556,723.69 |
| Dec 31, 2020 | 700,563.70 |
| Jun 30, 2020 | 622,387.43 |
| Dec 31, 2019 | 10.20 Mn |
| Jun 30, 2019 | 11.32 Mn |
| Dec 31, 2018 | 10.55 Mn |
| Jun 30, 2018 | 2.23 Mn |
| Jun 30, 2017 | 4.34 Mn |
| Mar 31, 2017 | 4.23 Mn |
| Dec 31, 2016 | 5.18 Mn |
| Jun 30, 2016 | 3.75 Mn |